IMUX - Immunic files for $250M mixed securities shelf
2023-11-22 16:27:08 ET
More on Immunic
- Immunic: Latest CALLIPER Data Reinforces Vidofludimus Calcium For Multiple Sclerosis
- Immunic jumps after the bell on positive interim data from phase 2 CALLIPER trial
- Seeking Alpha’s Quant Rating on Immunic
For further details see:
Immunic files for $250M mixed securities shelf